Bank of New York Mellon
NARI

Bank of New York Mellon’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bank of New York Mellon’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-335,550
Closed -$17.1M – 4191
2024
Q4 		$17.1M Buy
335,550
+9
+0% +$442 ﹤0.01% 1658
2024
Q3 		$13.8M Sell
335,541
-52,827
-14% -$2.54M ﹤0.01% 1770
2024
Q2 		$18.7M Sell
388,368
-26,092
-6% -$1.16M ﹤0.01% 1622
2024
Q1 		$19.9M Sell
414,460
-70,209
-14% -$3.75M ﹤0.01% 1578
2023
Q4 		$31.5M Buy
484,669
+5,011
+1% +$302K 0.01% 1347
2023
Q3 		$31.4M Sell
479,658
-8,387
-2% -$528K 0.01% 1278
2023
Q2 		$28.4M Buy
488,045
+21,584
+5% +$1.36M 0.01% 1359
2023
Q1 		$28.8M Sell
466,461
-19,135
-4% -$1.15M 0.01% 1352
2022
Q4 		$30.9M Sell
485,596
-827
-0.2% -$60K 0.01% 1295
2022
Q3 		$35.3M Buy
486,423
+103,966
+27% +$7.74M 0.01% 1166
2022
Q2 		$26M Buy
382,457
+228,513
+148% +$16.4M 0.01% 1402
2022
Q1 		$14M Buy
153,944
+16,986
+12% +$1.39M ﹤0.01% 1888
2021
Q4 		$12.5M Buy
136,958
+2,239
+2% +$192K ﹤0.01% 1977
2021
Q3 		$10.9M Buy
134,719
+35,770
+36% +$3.01M ﹤0.01% 2072
2021
Q2 		$9.23M Buy
98,949
+27,480
+38% +$2.66M ﹤0.01% 2187
2021
Q1 		$7.65M Buy
71,469
+34,388
+93% +$3.57M ﹤0.01% 2245
2020
Q4 		$3.24M Buy
37,081
+7,439
+25% +$525K ﹤0.01% 2564
2020
Q3 		$2.05M Buy
+29,642
New +$1.91M ﹤0.01% 2652

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Bank of New York Mellon's NARI Position: Q1 2025 in Review

Bank of New York Mellon sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 335,550 shares — an estimated $17.1M sold.

Bank of New York Mellon first reported a position in NARI in Q3 2020 and held it in 18 quarters. The position peaked at $35.3M in Q3 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Bank of New York Mellon reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 335,550 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $17.1M.
  • Bank of New York Mellon first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • Bank of New York Mellon's Inari Medical, Inc. Common Stock position peaked at $35.3M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Bank of New York Mellon's 13F filing for Q1 2025, filed 29 Apr 2025.